InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+0.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Shimer Julie Ann, Director. Officer active across 5 companies, notably MASIMO CORP. Aggregated, 13 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €9k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 27 July 2026 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Shimer Julie Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
50,090 shares@ US$25.000.11% mcap99.2% of flowCommon StockSEC:0001606498-26-000109:0
12,003 shares0Common StockSEC:0001606498-25-000008:0
500 shares@ US$19.85100.0% of flowCommon StockSEC:0001606498-24-000043:0
Canonical exit: 9 Jun 2024 (T+90)
8,378 shares0Common StockSEC:0001606498-24-000008:0
1,435 sharesCommon StockSEC:0000937556-23-000123:0
36,021 sharesCommon StockSEC:0001251769-23-000021:0
7,008 shares0Common StockSEC:0001606498-23-000005:0
14,224 shares0Common StockSEC:0001251769-22-000057:0
922 shares@ US$139.340.0013% mcap31.0% of flowCommon StockSEC:0000937556-22-000105:0
5,354 shares0Common StockSEC:0001606498-22-000002:0
3,888 shares0Common StockSEC:0001251769-21-000080:0
749 shares@ US$216.7952.7% of flowCommon StockSEC:0000937556-21-000106:0
4,274 sharesCommon StockSEC:0001209191-16-089560:0
13 of 13 declarations
About Shimer Julie Ann
Shimer Julie Ann is Administrateur and is listed as a director at Avanos Medical, INC., MASIMO CORP, Apollo Endosurgery, Inc. and Halyard Health, Inc. She has 13 filings in total, and across the 13 sampled filings from 2016-01-06 to 2026-07-28, the volumes are 9070 EUR in buys and 1097597 EUR in sells, with the dominant transaction nature being Attribution.
